Assessment of Cytotoxic Properties of Tetrahydroisoquinoline Oximes in Breast, Prostate, and Glioblastoma Cancer Cells

Recent studies have shown that some tetrahydroisoquinoline (THIQ) oximes induce cytotoxic effects and trigger apoptosis in various cell types. Since this pathway activation is desirable for anticancer drugs, scientists further explored the effects of three selected THIQ oximes on well-known cancer cell models: breast, prostate cancer, and malignant glioblastoma).